JP2014500257A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500257A5
JP2014500257A5 JP2013539370A JP2013539370A JP2014500257A5 JP 2014500257 A5 JP2014500257 A5 JP 2014500257A5 JP 2013539370 A JP2013539370 A JP 2013539370A JP 2013539370 A JP2013539370 A JP 2013539370A JP 2014500257 A5 JP2014500257 A5 JP 2014500257A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutical formulation
hyaluronic acid
formulation according
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013539370A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500257A (ja
JP6092781B2 (ja
Filing date
Publication date
Priority claimed from ITPD2010A000349A external-priority patent/IT1402786B1/it
Application filed filed Critical
Publication of JP2014500257A publication Critical patent/JP2014500257A/ja
Publication of JP2014500257A5 publication Critical patent/JP2014500257A5/ja
Application granted granted Critical
Publication of JP6092781B2 publication Critical patent/JP6092781B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013539370A 2010-11-19 2011-11-04 抗菌および創傷治癒活性を持つ組成物 Active JP6092781B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPD2010A000349A IT1402786B1 (it) 2010-11-19 2010-11-19 Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
ITPD2010A000349 2010-11-19
PCT/IB2011/054923 WO2012066447A1 (en) 2010-11-19 2011-11-04 Compositions with antibacterial and wound healing activity

Publications (3)

Publication Number Publication Date
JP2014500257A JP2014500257A (ja) 2014-01-09
JP2014500257A5 true JP2014500257A5 (enExample) 2014-10-23
JP6092781B2 JP6092781B2 (ja) 2017-03-08

Family

ID=43742908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013539370A Active JP6092781B2 (ja) 2010-11-19 2011-11-04 抗菌および創傷治癒活性を持つ組成物

Country Status (15)

Country Link
US (1) US9265793B2 (enExample)
EP (1) EP2640401B1 (enExample)
JP (1) JP6092781B2 (enExample)
CN (1) CN103249419B (enExample)
AU (1) AU2011330855B2 (enExample)
BR (1) BR112013012120A2 (enExample)
CA (1) CA2815810C (enExample)
ES (1) ES2588397T3 (enExample)
IL (1) IL226220A (enExample)
IT (1) IT1402786B1 (enExample)
MX (1) MX2013005593A (enExample)
RU (1) RU2611046C2 (enExample)
SI (1) SI2640401T1 (enExample)
SM (1) SMT201600381B (enExample)
WO (1) WO2012066447A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
CN103191461B (zh) * 2013-04-26 2015-09-16 华熙福瑞达生物医药有限公司 一种含透明质酸的伤口护理用敷料
ITMI20130883A1 (it) 2013-05-30 2014-12-01 Eurores S R L Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
US20150064129A1 (en) * 2013-09-04 2015-03-05 Taiwan Biotech Co., Ltd. Wound healing composition
KR20230052921A (ko) * 2020-08-17 2023-04-20 휴먼웰 파마슈티컬 유에스 지속성 인-시투(in-situ) 형성/겔화 조성물
TWI823516B (zh) * 2022-08-10 2023-11-21 鈺永科技有限公司 由有機鍺化合物和葡萄糖胺化合物製備的藥物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291123C (en) * 1986-03-14 1991-10-22 Abraham Nimrod Heavy metal salts of hyaluronic acid useful as antimicrobial agents
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
JP2002173405A (ja) * 2000-12-04 2002-06-21 Hidehiro Tagusari コロイド銀による殺菌方法及びこれを用いた殺菌処理材
EP1536845B1 (en) * 2002-09-11 2007-04-25 Johnson & Johnson Medical Ltd. Wound dressing materials comprising complexes of anionic polysaccharides with silver
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
DE10340277B4 (de) * 2003-08-29 2006-11-23 Bio-Gate Bioinnovative Materials Gmbh Körperpflegemittel mit Silber-Agglomeraten
CN1859881A (zh) * 2003-09-30 2006-11-08 库尔斯恩蒂斯股份公司 用于矫形植入物的抗微生物透明质酸涂层
US20050112151A1 (en) * 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2369408C2 (ru) * 2004-07-09 2009-10-10 Ферросан А/С Гемостатическая композиция, включающая гиалуроновую кислоту
DE102005008299B4 (de) * 2005-02-23 2025-07-10 Bio-Gate Ag Kosmetische und/oder dermatologische Formulierung, Verfahren zu deren Herstellung und Verwendung der Formulierung
EP2061528A1 (en) * 2006-09-13 2009-05-27 DSMIP Assets B.V. Antimicrobial hydrophilic coating comprising metallic silver particles
DE102007044582A1 (de) * 2007-09-19 2009-04-09 Deckner, Peter G., Dr. med. Zusammensetzung für Wundbehandlungen im Humanbereich
DE102007044583A1 (de) * 2007-09-19 2009-04-09 Deckner, Peter G., Dr. med. Zusammensetzung für Wundbehandlungen im Veterinärbereich
DE102008031023A1 (de) 2008-06-30 2009-12-31 Neubourg Skin Care Gmbh & Co. Kg Schaumhautpflegecreme
EP2218447B1 (en) * 2008-11-04 2017-04-19 PharmaSol GmbH Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
WO2010127647A1 (de) * 2009-05-08 2010-11-11 Deckner Peter G Zusammensetzungen für wundbehandlungen im human-, und veterinärbereich

Similar Documents

Publication Publication Date Title
JP2014500257A5 (enExample)
Tiwari et al. Local drug delivery strategies towards wound healing
CL2011002755A1 (es) Composicion farmaceutica topica que comprende particulas de fosfato de calcio nanoporosas, esfericas, donde al menos 90% o mas de las particulas tienen un diametro promedio de 2 micrometros o menos y estan enlazadas a un agente farmacologicamente activo.
JP5724108B2 (ja) 凍結乾燥組成物
JP2016516808A5 (enExample)
JP2011116788A5 (enExample)
JP2009280627A5 (enExample)
JP2017527539A5 (enExample)
JP2004536045A5 (enExample)
JP4838242B2 (ja) アルギネートを含む多孔性成型品の製造方法
JP2014510590A5 (enExample)
JP2010254688A5 (enExample)
JP2014505733A5 (enExample)
NZ703808A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
RU2013127673A (ru) Композиции с антибактериальной и ранозаживляющей активностью
JP2016517888A5 (enExample)
JP2015536939A5 (enExample)
JP2017514825A5 (enExample)
Pérez-Díaz et al. Nanoparticle and nanomaterial involvement during the wound healing process: an update in the field
JP2016540825A5 (enExample)
WO2014127016A3 (en) Ultrapure tetrahydrocannabinol-11-oic acids
RU2015102772A (ru) Бензодиазелипы для мелкоклеточного рака легкого
WO2012051614A3 (en) Delivery of hydrophobic bioactive agents
WO2015019304A3 (fr) Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales